Apply for the Creative Destruction Lab 2019/2020 Program
The Creative Destruction Lab is now accepting applications from startups for its 2019/20 seed-stage program for founders pursuing commercial opportunities predicated on translational science and technology innovations that improve human health and wellness.
Apply for the CNE Emerging Entrepreneurs Competition, August 23-25
Canada’s brightest innovators will converge in the CNE Innovation Garage over the fair's middle weekend to pitch their cutting edge inventions and compete for prize money up to $25,000 and in-kind services.
Apply for the ECHO Program
The Entrepreneurship for Cardiovascular Health Opportunities (ECHO) provides innovators of cardiovascular technologies with entrepreneurship training, mentorship, networking, and funding opportunities.
Vena Medical Announced as 2019 ONtrepreneur
Vena Medical was accepted into the Ontario Brain Institute's ONtrepreneur program, which provides an investment of $50,000 as well as 12 months of training opportunities, one-on-one mentorship and communications support.
Curiato and TGHC Officially Launch "Smart Bedsheet" Research
Braze Mobility Awarded First Place at RBC Investor Event
Hosted by RBC in partnership with the Rick Hansen Institute, eight shortlisted international and Canadian startups that develop spinal cord injury products pitched their businesses to a panel of corporate and scientific experts, with Braze Mobility winning first place.
Flosonics Medical Chosen to Participate in Medtech Innovator's Program
MedTech Innovator announced Flosonics Medical as one of 50 companies selected to participate in the organization’s flagship four-month program, which will offer access to leading manufacturers, providers, investors, and other industry stakeholders.
Waterloo Region Now Home to Canada's First Industry-Led Medical Technology Hub
The Medical Innovation Xchange is Canada's first industry-led hub dedicated to supporting southern Ontario medtech start-ups achieve global scale while keeping their headquarters in Waterloo Region, and will house anchor tenant Intellijoint Surgical who will be joined by Penta Medical, Vena Medical, and Bloom Care Solutions.
Spiderwort Announces $500,000 Raise
Spiderwort announced the raise of $500,000 CAD as part of its oversubscribed Friends and Family round, along with naming new advisory board members.
Join the Ontario Trade Mission to AdvaMed, September 22-25
The Export Business Services Branch (EBSB), Ontario Ministry of Economic Development, Job Creation and Trade, is organizing a Trade Mission to attend the AdvaMed MedTech Conference in order to facilitate introductions for Ontario companies to potential customers, partners and investors.
Apply to Join a Canadian Technology Accelerator
The Canadian Technology Accelerator (CTA) initiative helps Canadian companies with an existing technology, product or service explore opportunities in foreign markets. Life Science sector sessions run in Boston, San Francisco, and Singapore.
Apply to Join the Canadian Nanotechnology PDA Mission, September 23-27 in Sao Paulo, Brazil
This Partnership Development Activity mission will focus on introducing Canadian SMEs to potential Brazilian partners for industrial R&D collaboration specific to nanotechnology with applications to the biotechnology, medicine, pharmaceuticals and cosmetics sectors.
Thornhill Medical Device Contributes to New CardioImaging Study
Thornhill Medical's investigative tool RespirAct™ Gas Control System contributed to international team led by scientists from Lawson Health Research Institute and Cedars-Sinai Medical Center.
SickKids Receives $100M Donation for Hospital Rebuild
The Hospital for Sick Children announced a $100-million donation made by Mattamy Homes founder Peter Gilgan, the largest single donation in the hospital’s history.
FACIT Portfolio Announces $750M Follow-On Financing
FACIT announced a new commercialization milestone with $750M in follow-on financing and partnerships attracted by its seed investment portfolio.
Antibe Therapeutics Unveils Lead Indication for Second Pipeline Drug
Antibe Therapeutics announced the lead indication for its second pipeline drug, ATB-352, a potent and non-addictive analgesic for the treatment of severe pain.
Apply for Sunnybrook's Fall Medventions Internship Program
The Medventions internship program is a fast-paced, project-based training structure for students and recent graduates with a passion for entrepreneurship and a commitment to improving health care for patients around the world through technology innovation and commercialization.
Cyclica Announces Launch of Ligand DesignTM
Cyclica has announced its novel, first-in-class drug design technology, Ligand DesignTM which empowers scientists in the pharmaceutical industry to generate novel drug-like compounds by combining powerful methods for molecule generation, ADMET prediction, and high-throughput ligand-protein interaction prediction.
$100 M Endowment Fund Announced for Health Sciences Research in Hamilton
Philanthropists Charles and Margaret Juravinski will create an endowment of more than $100 million to equally support Hamilton Health Sciences, McMaster University and St. Joseph’s Healthcare Hamilton by funding health research in a variety of areas including cancer, mental health, lung and respiratory care, and diseases of aging.
Apply for Financial Support to Attend AdvaMed, September 22-25
Medtech Canada (formerly MEDEC) received assistance from Global Affairs Canada to provide financial support for 10 Canadian medtech companies to participate at the AdvaMed MedTech Conference in Boston.